Skip to content

Role of Apamarga Ksharasutra and Palasha Ksharasutra in the treatment of Nadi vrana w.s.r. to pilonidal sinus .

Comparative clinical study to evaluate the role of Apamarga Kshara sutra and Palasha kshara sutra in the mangement of Nadi vrana w.s.r to Pilonidal sinus. - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105437
Enrollment
40
Registered
2026-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L050- Pilonidal cyst and sinus with abscess

Interventions

None listed

Sponsors

Navneet kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.The patients who presented with the signs & symptoms of Nadi Vrana W.S.R. to Pilonidal Sinus 2.Age Group 18 years to 60 years 3.Gender Both Male & Female included in these clinical trials. 4.Single Sinus track situated at midline of natal cleft. 5.Patients with written Consent

Exclusion criteria

Exclusion criteria: 1.Patients aged below 18 and above 60 years of age 2.Patients who are sensitive to Xylocaine will be excluded 3.Pilonidal sinus more than 6 cm in length with multiple tract 4.Systemic diseases like Diabetic mellitus, tuberculosis and Malignant condition will be excluded. 5.Patients unfit for Surgical excision and Ksharasutra Ligation

Design outcomes

Primary

MeasureTime frame
Unit Cutting Time (days/cm)Timepoint: from the day of kaharasutra ligation till complete cut through od sinus tract

Secondary

MeasureTime frame
Pain assessed by visual analog scale (vas)Timepoint: day0, day7, day14.day21,day28 & weekly thereafter till complete cut through

Countries

India

Contacts

Public ContactDr Saurabh Kumar

Shri Dhanvantri Ayurved Medical College and Research Center,MATHURA

directorsdamcrc@gmail.com9266949403

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026